• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Thermo Fisher buys Brammer Bio for $1.7bn pharmatimes
    March 27, 2019
    Thermo Fisher, another life sciences group pitching in on the future of gene therapy, has announced plans to enter into a definitive agreement to acquire Brammer Bio for approximately $1.7 billion.
  • Brammer Bio, Sarepta Enter Long-term Mfg. Tie-up contractpharma
    June 19, 2018
    Sarepta Therapeutics, a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases, has entered into a long-term strategic manufacturing partnership with Brammer B
  • Brammer Bio expands Cell and Gene Therapy Capacity in Florida and Massachusetts biospectrumasia
    September 27, 2017
    Brammer Bio expands Cell and Gene Therapy Capacity in Florida and Massachusetts Both sites will feature Pall Life Sciences enabling technologies for efficient cell and gene therapy manufacturing.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service